LANCE RICHARD BRUCK, MD, FACOG, FACS

advertisement
LANCE RICHARD BRUCK, MD, FACOG, FACS
Chairman
Hugh K. Miller, MD Department of Obstetrics and Gynecology
Stamford Health System
EDUCATION:
1985-1989
Muhlenberg College
Allentown, PA
Bachelors of Science (Biology and Philosophy)
Magna Cum Laude
1989-1993
New York Medical College
Valhalla, NY
Medical Degree
POST-GRADUATE TRAINING:
1993-1996
Resident, Obstetrics and Gynecology
Albert Einstein College of Medicine
Montefiore Medical Center
Jacobi Medical Center
Bronx, NY
1995
Galloway Fellowship, Gynecologic Oncology
Memorial Sloan-Kettering Cancer Center
New York, NY
1996-1997
Chief Resident, Obstetrics and Gynecology
Albert Einstein College of Medicine
Montefiore Medical Center
Jacobi Medical Center
Bronx, NY
PROFESSIONAL EMPLOYMENT:
1996-1998
Obstetric and Gynecologic Consultant
Planned Parenthood of Nassau County
1997
Attending Physician - Jacobi Medical Center
Private Practice Attending Physician – Larchmont, NY
Riker’s Island High Risk Obstetric Consultant – Queens, NY
Montefiore Medical Center
1997-2005
Medical Director of Women’s Health Services
Jacobi Medical Center / North Bronx Healthcare Network
lbruck
Page 1
2/15/2016
1998-2007
Director of Gynecology
Jacobi Medical Center / North Bronx Healthcare Network
2005-2007
Director of Gynecologic and Reproductive Health Research
Jacobi Medical Center / North Bronx Healthcare Network
2006-2007
Vice Chairman
Department of Obstetrics, Gynecology and Women’s Health
North Bronx Healthcare Network
2007-present
Chairman
Department of Obstetrics and Gynecology
Stamford Health System
HOSPITAL APPOINTMENTS:
1997-2008
North Bronx Healthcare Network
Jacobi Medical Center
North Central Bronx Hospital
1997-2008
Montefiore Medical Center
2007-present
Stamford Health System
ACADEMIC APPOINTMENTS:
1997-2000
Instructor: Obstetrics, Gynecology and Women’s Health
Albert Einstein College of Medicine
2000-2006
Assistant Professor: Obstetrics, Gynecology and Women’s
Health
Albert Einstein College of Medicine
2001-2007
Site Director: Female Pelvic Medicine and Reconstructive
Surgery Fellowship Program
Albert Einstein College of Medicine
2006-present
Associate Professor: Obstetrics, Gynecology and Women’s
Health
Albert Einstein College of Medicine
Fellowship Director: Gynecologic Endoscopy
Affiliated with the AAGL and SRS
Jacobi Medical Center
North Bronx Healthcare Network
2007
BOARD CERTIFICATION:
lbruck
Page 2
2/15/2016
July 1994
Diplomate of the National Board of Medical Examiners
November 1999
Diplomate of the American Board of Obstetrics and Gynecology
PROFESSIONAL SOCIETY MEMBERSHIP:
Fellow of the American College of Obstetricians and Gynecologists
Fellow of the American College of Surgeons
American Urogynecologic Society
American Society for Colposcopy and Cervical Pathology
American Association of Gynecologic Laparoscopists
Association of Professors of Gynecology and Obstetrics
Society of Laparoendoscopic Surgeons
American College of Physician Executives
Bronx Gynecological and Obstetrical Society
Physicians for Reproductive Choice and Health
Alumni Association of New York Medical College
The Martin L. Stone Obstetrical and Gynecological Society
AWARDS AND HONORS:
1989
Lindback Scholarship for Academic Excellence and
Community Service
Muhlenberg College
1992
Schueuer Family Foundation Scholarship
New York Medical College
OTHER PROFESSIONAL ACTIVITIES:
1997-2007
New York Medical Alliance, PC
Member of the Board of Directors
2002-2007
New York Medical Alliance, PC
Corporate Officer
lbruck
Page 3
2/15/2016
2002-present
Peer Journal Reviewer
Obstetrics and Gynecology
2002-2007
Affinity Health Plan
Credentialing and Medical Peer Review Committee
2003-present
Rockshelter Consulting, PC
President
2004-present
American Cystoscope Manufacturers, Inc.
Medical Advisory Board
2005-2007
Faculty Editor
Einstein Journal of Biology and Medicine
2005-present
Gyrus Medical, Inc.
Medical Advisory Board
2005-present
Peer Journal Reviewer
The American Journal of Managed Care
2006-present
Board of Observers
Muhlenberg College
2007-present
Stamford OB/GYN Associates, PC
President
2007-present
Fairfield County OB/GYN, LLC
President
ALBERT EINSTEIN COLLEGE OF MEDICINE COMMITTEES
1997-2007
Departmental Committee for Resident Training
1997-2007
Ambulatory OB/GYN Elective Leader
1999-2007
Dean’s Letter Committee for Medical Students
2001-2007
Committee of Admissions
2002-2005
Department of Education
Education and Faculty Support Committee
2004-2005
Faculty Senate
2006-2007
Ad hoc Promotion Chair
GRANT SUPPORT:
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, 12-week
lbruck
Page 4
2/15/2016
study assessing the effects of femhrt on vasomotor symptoms in postmenopausal women
of minority ethnic groups.
Protocol#: A4111002. Sponsor: Pfizer. Sub-investigator. $42,062
Comprehensive Family Planning and Reproductive Health Care Services Grant
(2002-2009)
New York State Department of Health. Principal Investigator. $592,429/annum
A multicenter, phase III, double-blind, placebo-controlled, parallel study of ADL 8-2698
in opioid induced postoperative bowel dysfunction/postoperative ileus.
Protocol #: 14CL308. Sponsor: Adolor Corporation. Principal investigator. $102,293
Multi-center, double blind, randomized, placebo-controlled, multiple dose study of the
analgesic efficacy and safety of acetaminophen injection 1g vs. placebo for pain
following vaginal hysterectomy.
Protocol # 136-03-03. Sponsor: Bristol-Meyers-Squibb. Principal investigator. $36,510
SGN-00101 (HspE7) immunotherapy of CIN III.
Protocol # 5850. Sponsor: CTEP/NIH/Stresgen. Sub-investigator. $15,000
A double-blind, randomized, controlled phase III study to assess the prophylactic efficacy
and safety of gD Alum/MPL vaccine in the prevention of genital herpes disease in young
women who are HSV-1 and –2 seronegative.
Protocol # 208141/039. Sponsor: NIH/GlaxoSmithKline. Principal investigator. $1,835,740
A double-blind, randomized, controlled study to evaluate the immunogenicity and safety of
GlaxoSmithKline biologicals herpes simplex candidate vaccine (gD2-AS04) in healthy HSV
seronegative and seropositive female subjects aged 10-17 years.
Protocol # 208141/040. Sponsor: GlaxoSmithKline. Sub-investigator. $ 73,800
An international, randomized, double-blind, placebo-controlled, multicenter, 6-month
study of the efficacy and safety of valaciclovir 1g once daily vs. placebo for the
suppression of HSV-2 genital herpes in newly infected immunocompetent subjects.
Protocol # HS2100275. Sponsor: GlaxoSmithKline. Principal investigator. $24,552
An open-label study of the efficacy and safety of 5 and 10 mg Vesicare (solifenacin
succinate) in patients with overactive bladder (OAB) symptoms.
Protocol # 905-UC-007. Sponsor: Yamanouchi Pharma America, Inc.. Principal
Investigator. $19,500
Identification of genetic susceptibility loci in women with cervical cancer.
Protocol # K12 RR017672. Sponsor: NIH/NCRR. Sub-investigator. $145,173/annum
(2003-2007)
A randomized, double-blind, placebo-controlled, multi-center, two-way crossover study
to investigate the effect of Valtrex 1g once daily for 60 days on viral shedding in HSV-2
lbruck
Page 5
2/15/2016
seropositive subjects with no previous history of symptomatic genital herpes infection.
Protocol # VLX103596. Sponsor: GlaxoSmithKline. Principal Investigator. $27,790
A 12-week, randomized, open-label, parallel-group, multicenter study to evaluate the
efficacy, safety and tolerability of Enablex (darifenacin) (with voluntary up-titration
from 7.5mg o.d. to 15mg o.d. at week 2) alone or in combination with behavioral
modification for symptoms of overactive bladder.
Protocol # CAR328AUS01. Sponsor: Novartis Pharmaceuticals. Principal Investigator.
$30,551
A randomized, placebo-controlled phase II study of multiple dosing regimens of
intravaginally administered 851B gel for the treatment of cervical high risk HPV
infection.
Protocol # 1547-851B. Sponsor: 3M pharmaceuticals. Principal Investigator. $ 129,611
A phase II, randomized, double-blind, placebo-controlled, trial of the use of 4,4 –
dinitrophenyl-hydrazone (A-007) topical gel in the treatment of high-grade squamous
intraepithelial lesions (HSIL) of the cervix.
Protocol TG-001B. Sponsor: Tigris Pharmaceuticals. Principal Investigator. $ 66,195
A multi-center prospective clinical study to evaluate the performance and clinical
predictive value of the Invader® HPV HR Molecular Assay and Invader® HPV 16 / 18
Molecular Assay for the detection of Human Papillomavirus in cervical cytology
samples.
Protocol # DP0517. Sponsor: Third Wave Technologies, Inc. Principal Investigator.
$87,656
A Phase III Randomized, Double-Blind, Placebo-Controlled, Multi-Center, ParallelGroup, Single- and Multiple-Dose Study of the Analgesic Efficacy and Safety of
Intravenous Acetaminophen (IV APAP) Versus Placebo Over 48 Hours for the Treatment
of Postoperative Pain after a Total Abdominal Hysterectomy.
Protocol # CPI-APA-301. Sponsor: Cadence Pharmaceuticals, Inc.Principal
Investigator. $90,000
A phase IIIb, subject- and observer-blind, randomized, multicenter study with two
parallel groups to compare the immunogenicity of GlaxoSmithKline Biological’s HPV16/18 L1/AS04 vaccine versus Merck’s Gardasil® vaccine when administered
intramuscularly according to a 3-dose schedule in healthy adult females 18-45 years of
age.
Protocol # 108993/010. Sponsor: GSK Biologicals. Principal Investigator. $80,000
INVITED PRESENTATIONS:
Critical review of the routine postoperative fever evaluation on a gynecologic surgery
service. American College of Obstetricians and Gynecologists, 1998 Junior Fellow
Annual Meeting
lbruck
Page 6
2/15/2016
Management of ectopic pregnancy. North Bronx Healthcare Network. Bronx, NY.
Pediatric Emergency Medicine Grand Rounds. January 1999.
Evaluation and management of urinary incontinence. North Bronx Healthcare Network.
Bronx, NY. Internal Medicine Grand Rounds. February 2000.
A review of single dose methotrexate for the treatment of ectopic pregnancy. Health and
Hospitals Corporation 2001 Board Meeting
Management of surgical abortion complications. New Insights into Family Planning and
Abortion: Enhancing your Gynecologic Practice, 2002 Family Planning Update – New
York City Health and Hospital Corporation
Detection of cervical human papillomavirus infection by in-situ hybridization in fetuses
of women with squamous intraepithelial lesions. The American Society for Colposcopy
and Cervical Pathology, 2004 Biennial Meeting
Update on sexually transmitted infections. Bayshore Community Hospital. Holmdel, NJ.
Grand Rounds. July 2005.
The future of OB/GYN as a career path. Muhlenberg College. Allentown, PA. Invited
alumnus lecturer. November 2005.
Laparoscopic supracervical hysterectomy. Englewood Hospital. Englewood, NJ. Grand
Rounds. January 2006.
Management of adnexal masses. North Bronx Healthcare Network. Bronx, NY.
Emergency Medicine Grand Rounds. April 2006.
Cervical dysplasia prevention: HPV vaccination. Bronx Lebanon Hospital. Bronx, NY.
Grand Rounds. February 2007.
HPV vaccines: the new era in HPV management. Saint Vincent’s Medical CenterManhattan. New York, NY. Grand Rounds. April 2007.
HPV and the new vaccine era. Stamford Hospital. Stamford, CT. Grand Rounds. May
2007.
Management of Chronic Pelvic Pain. Cablevision - 12 on Health. November 2007
Hope for the Mid-life Female. Fairfield County Parish Nurse Grand Rounds. Stamford,
CT. May 2008.
Chronic Pelvic Pain – Causes and Treatments. GE Women’s Stay Healthy Lecture Series.
Stamford, CT. July 2008.
lbruck
Page 7
2/15/2016
COURSE DIRECTOR:
New Insights into Family Planning and Abortion: Enhancing your Gynecologic Practice,
2002 Family Planning Update – New York City Health and Hospital Corporation. Bronx,
NY.
New Technologies in Minimally Invasive Surgery. 2008 Annual Obstetric and
Gynecology Symposium – Stamford Health System. Stamford, CT.
BIBLIOGRAPHY:
Original Communications in Reviewed Journals:
Bruck LR, Sherer DM. Intrapartum sonography of the lower uterine segment in patients
with breech-presenting fetuses. American Journal of Perinatology 1997;14:315-6.
Cole DS, Bruck LR. Anaphylaxis after laminaria insertion. Obstetrics and Gynecology
2000;95:1025.
Lazarou G, Powers K, Pena C, Bruck L, Mikhail M. Inflammatory reaction following
bovine pericardium graft-augmentation for posterior vaginal wall defect repair.
International Urogynecology Journal and Pelvic Floor Dysfunction 2005;16:242-244.
Bruck LR, Zee S, Poulos B, Abadi M. Detection of cervical human papillomavirus
infection by in situ hybridization in fetuses of women with squamous intraepithelial
lesions. Journal of Lower Genital Tract Disease 2005;9:114-117.
Bruck LR, Lazarou G, Mussalli G, Bobby P. Surgical reconstruction of congenital
hypertrophy of the perineal body. Journal of Pelvic Medicine and Surgery 2006;12:219223.
Lazarou G, Powers K, Pena C, Bruck L, Mikhail M. Inflammatory response to bovine
pericardium: reply to letter by Davila. International Urogynecology Journal and Pelvic
Floor Dysfunction 2006; 17:551.
Abstracts:
Anderson PS, Smith HO, DeVictoria C, Hurde C, Fields AL, Bruck LR, Runowicz CD,
Goldberg GL. The potential role of preoperative CA19-9 in patients with endometrial
cancer. ACOG 1995 Annual Meeting. San Francisco, CA.
Bruck LR, Cole D, Goldberg GL. Critical review of the routine postoperative fever
evaluation on a gynecologic surgery service. ACOG 1998 Junior Fellow Annual Meeting.
New York, NY.
Simon BJ, Valentine N, Bruck LR. A retrospective chart review of single dose
methotrexate for the treatment of ectopic pregnancy at Jacobi Medical Center from 1998lbruck
Page 8
2/15/2016
2001. 3rd World Congress on Controversies in Obstetrics, Gynecology and Infertility.
Washington, DC.
Ng E, Damus K, Bruck LR, MacIsaac L. Advance provision of levonorgesterol-only
emergency contraception versus prescription. ACOG 2003 annual meeting.
New Orleans, LA.
Bruck LR, Zee SY, Poulos BK, Carroll DA, Abadi M. Detection of cervical human
papillomavirus infection by in-situ hybridization in fetuses of women with squamous
intraepithelial lesions. The American Society for Colposcopy and Cervical Pathology
2004 Biennial Meeting. Orlando, FL.
Abadi MA, Kra J, Bruck LR. Detection of HPV in fetal larynx. 24th International HPV
Meeting. Beijing, China.
Development of a bladeless tissue morcellator using plasma kinetic technology.
Anderson TL, Bruck LR, Lyons TL Advincula AP. 36th Global Congress of Minimally
Invasive Gynecology. Washington, DC.
lbruck
Page 9
2/15/2016
Download